The IPKat notes the following patent cases from outside his usual stomping ground:
* Mobile Burn notes that mobile phone manufacturers Nokia and Vitelcom have settled a patent dispute pending in the German and Spanish courts with a royalty bearing patent licence agreement covering certain Nokia patents relating to the GSM/GPRS Mobile Communication Standard and the grant of a cross licence to Nokia under Vitelcom patents in the same field. The IPKat notes that the press release by Nokia on the issue is very terse – if they came out on top, what’s the big secret?
* According to the Boston Business Journal, Genzyme is suing Transkaryotic in Israel, claiming that Transkaryotic has infringed its patent for glucocerebrosidase compound, which is used in the treatment of Gaucher disease. Both companies are based in Massachusettes so the IPKat would like to know, why Israel?
* The Financial Times reports that Sanofi-Aventis’ patent for the blood thinning drug Plavix is being challenged in the Scottish courts for lack of novelty by Aircoat. The IPKat welcomes the change for the Scottish courts to flex their IP muscles.
More Scottish patents here, here and here
Wednesday, 26 January 2005
Posted by Unknown at 01:31:00